Amgen (NASDAQ:AMGN) reported quarterly earnings of $5.15 per share which beat the analyst consensus estimate of $4.76 by 8.19 percent. This is a 5.1 percent increase over earnings of $4.90 per share from the same period last year. The company reported quarterly sales of $8.618 billion which beat the analyst consensus estimate of $8.579 billion by 0.45 percent. This is a 5.76 percent increase over sales of $8.149 billion the same period last year.